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Parkinson’s disease (PD) is an idiopathic dis-
ease of the nervous system characterized clini-
cally by parkinsonism: chronic progressive
tremor, bradykinesia, rigidity, and postural
instability. The major pathologic feature of
PD is the profound loss of pigmented neurons,
mainly in the pars compacta of the substantia
nigra (SN). Associated with this neuronal loss
is the presence of large eosinophilic inclusions,
called Lewy bodies, within the remaining pig-
mented neurons, made up of a series of pro-
teins, including neurofilaments, α-synuclein
ﬁbrils, ubiquitin, parkin, and proteasomal ele-
ments. The ﬁrst clinical signs of PD, however,
become apparent only after the loss of about
70–80% of dopaminergic neurons (Schapira
1999), and although the diagnosis of PD is
entirely clinical, histopathology on autopsy is
the only way to deﬁnitively conﬁrm a diagnosis.
The mean age of onset of PD is typically
between 60 and 65 years, and in Europe the
prevalence of PD has been estimated to be
1.8% in persons ≥ 65 years of age (de Rijk et al.
2000), with an incidence of approximately
16–19 per 100,000 per year (Twelves et al.
2003). Although age is unequivocally associated
with increasing PD risk, the underlying process
of PD is distinct from the natural aging process
(Goldman and Tanner 1998). PD prevalence is
also similar among ethnic groups living in the
same location (Morens et al. 1996), but may
differ among ethnic groups living in different
locations (Schoenberg et al. 1988). Genetic fac-
tors can inﬂuence the risk of PD, and higher
rates of PD have been found in relatives of
those with PD (Foltynie et al. 2002). However,
twin studies have consistently shown low rates
of concordance (5–8%) in monozygotic and
dizygotic twins (Foltynie et al. 2002), suggest-
ing that other factors play a part in the etiology
of PD. The exception to this is young-onset
PD (onset before 50 years of age), where con-
cordance in monozygotic twins was 100%, sug-
gesting a primarily genetic basis (Tanner 2003).
Several speciﬁc loci have been identiﬁed that
result in PD, including mutations in the
PARK 1 to PARK 8 genes, although these forms
of PD are rare and usually display atypical fea-
tures of the disease (Foltynie et al. 2002).
A number of causative factors have been
found to induce parkinsonism similar to that of
idiopathic PD, including vascular insults to the
brain, repeated head trauma, neuroleptic drugs,
and manganese toxicity (Adler 1999). In partic-
ular, the toxicant 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) resulted in the
development of acute parkinsonism, similar to
the idiopathic disease in nearly all clinical,
pathologic, and biochemical features, in a small
group of drug addicts (Langston et al. 1983).
This rekindled an interest in the possible role of
exogenous toxicants in the development of PD
and parkinsonism generally, in particular, com-
pounds that are toxicologically or structurally
similar to MPTP, including pesticides such as
rotenone and paraquat (Goldman and Tanner
1998). Numerous epidemiologic and toxico-
logic studies have examined pesticides as a risk
factor for PD and parkinsonism and the possi-
ble mechanisms by which pesticides may act. In
addition, a number of other related risk factors
have been found to be associated with the
development of PD, such as farming, rural
living, and consumption of well water.
To date, there has been no comprehensive
literature review of the epidemiologic and tox-
icologic evidence to critically evaluate whether
a causal relationship exists between exposure
to pesticides and the development of PD or
parkinsonism. In this article we summarize
such a critical review, undertaken on behalf of
the U.K. Advisory Committee on Pesticides.
Methods
We conducted a search of 10 major online bib-
liographic databases in April 2003 to identify
references pertaining to the role of pesticides in
the development of PD and parkinsonism. We
selected search terms used with reference to the
relevant indexing terms used in Embase
(Elsevier, New York, NY, USA) and MedLine
(National Institutes of Health, Bethesda, MD,
USA) and key words used in published litera-
ture. Supplemental literature searching meth-
ods included reviewing the reference lists of
reports obtained, searching current journal
issues, and consulting the Internet. Reports
were included in this review if they were origi-
nal reports, directly addressed the role of a pes-
ticide or pesticides in an aspect of PD or
parkinsonism, were in English or French lan-
guage, and were published from 1983 onward.
Epidemiologic Evidence
A large body of epidemiologic literature exists
concerning pesticides and PD, including case
reports, descriptive studies, and cohort studies,
although most studies have used a case–control
design. A review of case reports, case series, and
incidence, prevalence, mortality, and cohort
studies is available in the Supplementary
Material online (http://ehp.niehs.nih.gov/
docs/2005/8095/supplemental.pdf). Here we
summarize the case–control studies.
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tremor, bradykinesia, rigidity, and postural instability. It has been postulated that exogenous toxi-
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http://dx.doi.org/ [Online 7 September 2005]We identiﬁed 40 case–control studies pub-
lished since 1983; we excluded two of these
(Semchuk et al. 1993; Semchuk and Love
1995) from the review because the data were
included in another study (Semchuk et al.
1992) and the reports did not offer any new
data. Of the remaining 38 studies, 13 were
carried out in the United States, 5 in Canada,
11 in Europe, 5 in Asia, 2 in Australia, 1 in
South America, and 1 was from Nigeria.
Table S1 in the Supplementary Material
(http://ehp.niehs.nih.gov/docs/2005/8095/
supplemental.pdf) gives details of each of the
studies. Three of the studies were conference
abstracts (Table S1; http://ehp.niehs.nih.gov/
docs/2005/8095/supplemental.pdf), but we
chose to include them in our review because
they would have been peer reviewed before
being accepted. The results presented in these
abstracts do not differ significantly from the
overall findings from other studies. In addi-
tion, we identiﬁed three autopsy studies that
examined the levels of various pesticides and
their metabolites in the brains of PD cases
(Corrigan et al. 1998, 2000; Fleming et al.
1994). The number of cases in the studies
ranged from 34 to 496, and the number of
controls from 25 to 2,070, although one
nested case–control study used the rest of the
cohort (22,286) as their controls (Table S1;
http://ehp.niehs.nih.gov/docs/2005/8095/
supplemental.pdf). The mean age of the cases
ranged from < 50 years to 72 years.
Figure 1 presents a forest plot of the odds
ratios (ORs) for the 31 studies that presented
results for exposure to pesticides as an expo-
sure category. The ORs ranged from 0.75 to
7.0, with only two studies reporting an OR
< 1.0 (Figure 1). The ORs in the remaining
studies were greater than or equal to unity, of
which 12 reported a significant association
between pesticide exposure and the risk of
PD. In the studies that found a significant
relationship, the ORs ranged from 1.6 to 7.0.
Confidence intervals (CIs) for a number of
studies are wide, reﬂecting to some extent the
small sample sizes. Of the seven studies not
included in Figure 1, two qualitatively stated
that they found no association (Kirkey et al.
2001; Tanner et al. 1989), another reported
data for individual pesticide compounds only
(Wechsler et al. 1991), and four reported data
for individual groups of pesticides only [e.g.,
herbicides, insecticides (Behari et al. 2001;
Butterfield et al. 1993; Gorell et al. 1998;
Kamel et al. 2001)].
In a meta-analysis of 19 case–control
studies published between 1989 and 1999,
and using pesticides as an exposure category,
Priyadarshi et al. (2000) obtained a combined
OR for PD risk of 1.94 (95% CI, 1.49–2.53).
The authors also analyzed the data according
to geographic location and found the com-
bined estimates were similar: United States,
2.15 (95% CI, 1.14–4.05); Canada, 1.94
(95% CI, 1.37–2.76); Europe (including one
Australian study), 1.76 (95% CI, 1.41–2.21);
Asia, 2.53 (95% CI, 1.58–4.05). After
accounting for geographic location, hetero-
geneity remained between the studies. This
could be due to the different inclusion/exclu-
sion criteria used to define a case or because
of the various methods used to define pesti-
cide exposure.
Although most of the studies considered
only pesticides or pesticides and herbicides as
the exposure category, several studies
attempted to examine the effects of exposure
to more speciﬁc groups of pesticides (e.g., her-
bicides, insecticides). The ORs and 95% CIs
for these studies are presented in Figure 2. In
most studies, a positive association was
observed between exposure to herbicides and
PD risk. In one study, exposure to herbicides
was a signiﬁcant independent risk factor after
adjustment for insecticide and other exposures
(Semchuk et al. 1992). Exposure to insecti-
cides is also generally positively associated with
PD (Figure 2). Fungicide exposure was not
found to be a significant risk factor for PD,
nor was exposure to rodenticides (Behari et al.
2001) or acaricides (Hertzman et al. 1994;
data not shown). 
Several studies investigated the relation-
ship between exposure to individual pesticides
and PD risk. In two studies, paraquat expo-
sure was shown to be signiﬁcantly associated
with PD (Hertzman et al. 1990; Liou et al.
1997), especially with > 20 years of exposure
(Liou et al. 1997). However, other studies
have not found a significant association,
although PD risk was still elevated (Firestone
et al. 2005; Hertzman et al. 1994; Kamel et al.
2001). Other speciﬁc groups of pesticides have
also shown positive associations with PD,
including organochlorines (Figure 2). Three
autopsy case–control studies found increased
levels of dieldrin and lindane in the brains of
deceased PD patients compared with other
diseased brains (Corrigan et al. 1998, 2000;
Fleming et al. 1994). Positive associations
were also seen with exposure to organophos-
phates and carbamates pesticides (Firestone
et al. 2005; Wechsler et al. 1991; data not
shown), although in only one study was the
association signiﬁcant (Seidler et al. 1996).
The relationship between exposure dura-
tion and PD risk was investigated in six case–
control studies. Four found a signiﬁcant associ-
ation between increasing pesticide exposure
duration and PD risk (Chan et al. 1998; Gorell
et al. 1998; Liou et al. 1997; Seidler et al.
1996), although the relationship in one study
did not remain signiﬁcant after adjusting for
various confounding factors (Chan et al.
1998). The remaining two studies showed
nonsigniﬁcant positive associations with expo-
sure duration (Jiménez-Jiménez et al. 1992;
Zayed et al. 1990). These studies suggested
that PD risk is increased when the duration of
exposure to pesticides exceeds a particular
threshold, because associations were often only
significant for the longest exposure duration
categories (e.g., > 10 or > 20 years). A positive
association was also observed with high doses
of pesticides compared with low doses (Nelson
et al. 2000), although the risk with regular use
was seen to be lower compared with occasional
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Figure 1. Forest plot of case–control studies examining pesticide exposure and the risk of developing PD.
(a) Results taken from meta-analysis of Priyadarshi et al. (2000). (b) Unmatched calculation; ﬁgures unavailable for matched
analysis. (c) Adjusted OR. (d) Assuming no missing responses and using cardiovascular patient control group. (e) Exposure
to pesticides and fertilizers.use (Kuopio et al. 1999). In addition, several
studies observed a positive correlation with
duration of exposure to, and high doses of,
herbicides and insecticides (Nelson et al. 2000;
Seidler et al. 1996). Signiﬁcant increases in PD
risk were also associated with a history of occu-
pational use of pesticides between the ages of
26 and 35 years, herbicides between the ages of
26 and 35, 36 and 45, and 46 and 55 years,
and insecticides between the ages of 46 and
55 years (Semchuk et al. 1992).
A number of potentially confounding
exposures, such as well-water consumption,
farming, and rural living, have also been found
to be associated with an increased risk of PD in
a number of studies. In a few of these studies,
multivariate analyses were performed to exam-
ine the relationship between the various risk
factors. Koller et al. (1990) found that well-
water consumption was dependent on rural
living, suggesting the risk factors were inter-
related. In one study, well-water use was found
to be positively and independently associated
with PD (Zorzon et al. 2002), and a meta-
analysis indicated the overall risk estimate to be
1.26 (95% CI, 0.96–1.64; Priyadarshi et al.
2001). Several studies have also found farming
to be an independent risk factor, in addition
to pesticide exposure (Gorell et al. 1998;
Zorzon et al. 2002), and the meta-analysis of
Priyadarshi et al. (2001) gave a combined risk
estimate of 1.42 (95% CI, 1.05–1.91).
Age is unequivocally associated with
increasing risk of PD and, along with sex, was
used as the major matching criterion for con-
trol selection in most of the reports reviewed or
was adjusted for in multivariate analyses. In the
epidemiology of PD, significant associations
have been reported with several other risk fac-
tors, including head trauma and family history
(positive associations), and smoking and caf-
feine intake (negative associations). A recent
meta-analysis (Hernán et al. 2002) showed that
the overall risk of PD was 30% lower among
coffee drinkers and 60% lower among smok-
ers, suggesting that these factors are protective.
However, although 21 of the 38 case–control
studies reported ORs for the association
between PD and smoking, few adjusted for it
in any multivariate analysis.
Study design issues. Although the ﬁndings
are consistent with an association between PD
and pesticide exposure, there are a number of
study design issues that need consideration
when interpreting the results of the epidemi-
ology studies.
Case ascertainment and control selection.
Many studies selected cases and controls from
hospitals or clinics. Other sources of cases
included lists of patients receiving anti-PD
drugs, residential care centers, community or
support groups, or door-to-door surveys.
Sources of controls included the general popu-
lation, the spouses of cases, electoral rolls, sub-
jects suggested by their cases, and friends and
relatives of the cases. Use of hospitals could
result in selection bias for both cases and con-
trols if attendance was influenced by factors
such as severity of PD (with particularly severe
or mild conditions being admitted elsewhere or
not attending), geographic location, and social
class. The use of neighborhood controls or
friends and relatives of cases can result in the
exposure prevalence being similar in both cases
and controls, resulting in overmatching, dri-
ving the risk estimate toward the null.
Study size. The size of the studies iden-
tiﬁed varied considerably. Power calculations
were given in only two of the 38 case–control
studies we identified, with the sample size
being sufficient to detect a difference in one
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Figure 2. Forest plot of case–control studies looking at exposure to speciﬁc groups of pesticides or individual pesticide compounds and the risk of developing PD.
(a) Adjusted OR. (b) Results taken from the meta-analysis of Priyadarshi et al. (2000). (c) Men only; cases compared with control group of patients with chronic cardiovascular disease.
(d) Cases compared with regional controls. (e) OR recalculated from data presented.
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categorystudy (Seidler et al. 1996) but not in the other
(Kirkey et al. 2001). A third study stated it had
sufﬁcient power to detect a difference in rela-
tion to pesticides as an exposure category but
not in relation to subgroups of pesticides
(Semchuk et al. 1992). The sample size
required for an unmatched case–control study
to detect an OR of 2.0 [based on Priyadarshi
et al. (2000)] with a signiﬁcance level of 0.05
and 90% power, assuming an estimated expo-
sure rate (proportion exposed) among the con-
trols of 0.10, would be slightly < 400 each for
cases and controls. For ORs > 2.0, the sample
size needed would be smaller, and for an
increased proportion exposed among the con-
trols, the sample size required would be larger.
In matched case–control studies, the power
and sample size depend on the expected num-
ber of discordant pairs (i.e., pairs in which the
case and control have different exposures). Of
the 38 case–control studies identified, only
three had > 375 cases (Behari et al. 2001;
Nelson et al. 2000; Seidler et al. 1996); the
majority (31 studies) had ≤ 150 cases
(Table S1; http://ehp.niehs.nih.gov/docs/
2005/8095/supplemental.pdf). The ORs for
most of the studies were < 2.0 with various pro-
portions of exposed controls, giving powers to
detect an association of much less than 90%.
Diagnosis. A variety of diagnostic criteria
were used in the studies reviewed. A number of
studies simply stated diagnosis was conﬁrmed
by a neurologist, but most defined a case on
the basis of the presence of two or more of the
cardinal signs of PD (tremor, rigidity, brady-
kinesia, and postural instability); some also
used additional criteria, including responsive-
ness to L-dopa therapy and/or a progressive
disorder. Other diagnostic criteria used
included the Unified Parkinson’s Disease
Rating Scale, the Hoehn and Yahr PD Staging
Scale, and the UK PD Society Brain Bank
Clinical Diagnosis Criteria (Fahn and Elton
1987; Hoehn and Yahr 1998; Hughes et al.
1992a) (Table S1; http://ehp.niehs.nih.gov/
docs/2005/8095/supplemental.pdf).
Clinicopathologic studies have assessed the
accuracy of these criteria and shown signiﬁcant
false-positive and false-negative rates for diag-
nosing PD (Hughes et al. 1992b; Litvan et al.
1998, 2003). Misdiagnosis is especially com-
mon during the early stages of the disease, even
among movement disorder specialists (Litvan
et al. 1996). The Movement Disorder Society
Scientiﬁc Issues Committee suggested that this
limitation could strongly affect the power of
epidemiologic studies and clinical trials (Litvan
et al. 2003) to detect a risk, by classifying indi-
viduals as cases when they should not be.
Statistical analysis. Multiple comparisons
were carried out in all the case–control studies.
Some of the observed associations may there-
fore have occurred by chance alone. Only a
few studies adjusted PD risk from pesticide
exposure for other factors or carried out multi-
variate logistic regression of the data. Some of
the studies that did undertake multivariate
analysis did not include pesticide exposure in
the predictive models (Behari et al. 2001;
McCann et al. 1998; Preux et al. 2000; Wong
et al. 1991; Zorzon et al. 2002). A few studies
found that pesticide exposure was not a signif-
icant risk factor after adjustment for con-
founding variables (Chan et al. 1998; Stern
et al. 1991; Taylor et al. 1999; Werneck and
Alvarenga 1999). In contrast, pesticide expo-
sure was shown to be a signiﬁcant risk factor
after adjustment in several studies (Butterﬁeld
et al. 1993; Gorell et al. 1998; Hertzman et al.
1990; Hubble et al. 1993; Liou et al. 1997;
Menegon et al. 1998; Seidler et al. 1996;
Semchuk et al. 1992; Zorzon et al. 2002).
These studies were not consistent in the vari-
ables used to adjust risk, and some did not
include risk factors found to be associated
with PD and related to pesticide exposure,
such as rural living, well-water consumption,
and farming as an occupation, which could
result in residual confounding. Studies that
have investigated these factors in relation to
PD have found ORs to be generally of the
same order and direction as those for pesticide
exposure. Many studies have postulated that
these factors and exposure to pesticides are
closely linked and interrelated. However,
there still remains uncertainty as to the exact
nature of the relationship between farming,
rural living, and pesticide exposure and their
relationship to PD risk.
Exposure assessment. Assessment of expo-
sure to pesticides relied upon subjects recalling
their lifetime exposures over some previous
20–30 years, leading potentially to differential
recall bias. For individuals occupationally
exposed to pesticides, the accuracy of their his-
torical self-reported pesticide exposure was
high for broad categories of pesticides and
commonly used pesticides, but not for speciﬁc
pesticides (Engel et al. 2001; Hoppin et al.
2002). However, the accuracy of recall for
nonoccupational or residential exposure is
questionable (Teitelbaum 2002), and the
authors of most studies stated that they were
unable to identify specific pesticides used,
owing to the subjects’ lack of knowledge about
their exposures. A few studies cross-checked
the answers to the administered questionnaire
on a small sample of subjects and showed good
test/retest reliability (Butterfield et al. 1993;
Hertzman et al. 1990; Hubble et al. 1993;
Koller et al. 1990; Wang et al. 1994). The
questions used to assess pesticide exposure var-
ied considerably between studies and in some
reports were not given. A number of studies
simply asked “Have you ever been exposed to
pesticides?” (Behari et al. 2001; Kuopio et al.
1999; Preux et al. 2000; Smargiassi et al. 1998;
Tanner et al. 1989; Wechsler et al. 1991;
Zorzon et al. 2002), whereas others asked more
detailed questions, such as “Have you sprayed
pesticides or insecticides at least once a year for
5 years (not necessarily consecutively)?” (Golbe
et al. 1990) and “Have you been exposed to
pesticides for more than 20 days during a year
for at least 10 years?” (Duzcan et al. 2003). For
all these, if a positive answer was given to the
question, then the participant was deemed to
have been exposed to pesticides. It is thus likely
that the exposures estimated from these ques-
tions will not be the same and that the estima-
tions of PD risk for subjects classiﬁed as ever or
never exposed in these studies are probably not
comparable. In addition, the assessment of
exposure in most studies does not take into
account the timing of exposure compared
with onset of symptoms, the dose of pesticide,
the mechanism of exposure, or the chemical
classes of the pesticides. Furthermore, the
exposure category pesticides represents many
hundreds of chemicals, and these may not be
comparable between studies. It could be that
exposure to only a few pesticide compounds
results in an increased risk of developing PD;
however, differences in exposure to these com-
pounds would be masked by the use of broad
pesticide exposure categories in these studies,
probably contributing to the heterogeneity in
risk estimates observed.
Toxicologic Evidence
Given the complexity of the many factors and
substances to which the populations described
in the epidemiologic studies have been exposed,
in this section we review experimental studies
on relevant pesticides to gain an insight on
whether single or groups of pesticides, or related
substances, may contribute to the apparent
increase in PD seen in these populations. The
likely underlying cellular mechanisms of PD
and the involvement of exogenous factors are
summarized in Figure 3. These are discussed
further in the Supplementary Material
(http://ehp.niehs.nih.gov/docs/2005/8095/
supplemental.pdf).
There are a number of factors that should
be considered when assessing the mechanistic
evidence for a role for pesticides in PD
development and to identify further candi-
date substances for consideration in experi-
mental or epidemiologic studies: a) effects on
the striatal dopaminergic system (these may
include a decrease in dopamine levels and/or
an increase in dopamine turnover as a short-
term compensatory mechanism, which would
be identiﬁed by an increase in metabolites or
the enzyme tyrosine hydroxylase); b) effects
on the SN (most dopaminergic neurons are
present in the basal ganglia, including the SN,
and changes in the SN—although not necces-
sarily specific—would be expected to occur
with an agent involved in the development of
PD); and c) mechanistic effects (for example,
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tion/complex I inhibition, and α-synuclein
levels and aggregation.
Pesticides. Potential mechanisms of toxic-
ity of a number of speciﬁc pesticides are con-
sidered below.
Rotenone. Rotenone is a naturally occur-
ring insecticide and is a well-characterized,
high-affinity specific inhibitor of complex I
(NADH-dehydrogenase). It is extremely
hydrophobic and crosses biologic membranes
easily. Therefore, unlike MPTP, rotenone
does not require a dopamine transporter
(DAT) for access to the cytoplasm and there-
fore is likely to produce systemic inhibition of
complex I (Betarbet et al. 2000).
Continuous infusion of rats with rotenone
reduces speciﬁc complex I binding by 75%, at
a low free-rotenone concentration in the brain
of about 20–30 nmol/L, accompanied by
nigrostriatal dopaminergic lesions, suggesting
that striatal nerve endings are affected earlier
and more severely by rotenone than are nigral
cell bodies (Betarbet et al. 2000). Rats with
these lesions had cytoplasmic inclusions con-
taining α-synuclein in the nigral neurons,
which resembled the pale body precursors to
Lewy bodies found in humans with PD.
Rotenone-treated animals also developed
motor and postural deficits characteristic of
PD, the severity of which correlated with the
extent of the pathologic lesions, even after ces-
sation of the rotenone treatment. However,
Betarbet et al. (2000) also reported that
rotenone seems to have little toxicity when
administered orally (Sherer TB, Greenamyre
JT, unpublished data).
Other experiments suggest that dopamin-
ergic synapses in the SN pars compacta and in
the nigrastriatal pathway are sensitive to the
action of rotenone (Alam and Schmidt 2002).
This is in contrast to the ﬁndings of Betarbet
et al. (2000), who found that changes in the
SN were later events. In behavioral tests, the
treated animals showed a dose–dependent
increase in catalepsy and decrease in loco-
motion. The authors surprisingly suggested
that this (sub)chronic intraperitoneal dosing
was comparable with chronic environmental
exposure and was thus comparable with a
real-life situation.
In mice and rat neuron–glial cell cultures,
a nontoxic or minimally toxic concentration
of rotenone and the inflammatory agent
lipopolysaccharide synergistically induced
dopaminergic degeneration (Gao et al. 2003).
Niehaus and Lange (2003) have suggested that
inﬂammatory factors such as lipopolysaccha-
ride might be an environmental factor in the
development of PD. The presence of brain
microglia has been implicated in rotenone
neurotoxicity, and these cells release reactive
oxygen species as well as inﬂammatory factors
(Gao et al. 2002; Liu and Hong 2003).
Paraquat. Paraquat is a nonselective con-
tact herbicide with high pulmonary toxicity
(Corasaniti et al. 1998). One of the major
considerations in relation to the potential
neurotoxicity of paraquat is the extent to
which it can cross the blood–brain barrier
(BBB). Paraquat is a charged molecule, which
may not cross the BBB, and it is not metabo-
lized to a species more likely to gain access to
the brain (Sanchez-Ramos et al. 1987). Naylor
et al. (1995) found that after subcutaneous
administration to neonatal, adult, and aging
rats, most of the paraquat associated with
structures lying outside the BBB (pineal gland
and linings of the cerebral ventricles) or with-
out a BBB [anterior portions of olfactory bulb,
hypothalamus, and area postrema (Naylor
et al. 1995; Widdowson et al. 1996)]. Overall,
paraquat did not appear to pose a major
neurotoxicologic risk in brain areas with a
functional BBB. However, in the only study
identiﬁed in which paraquat was given orally,
neonatal mice dosed on gestation days 10 and
11 showed hypoactivity and reductions in stri-
atal dopamine and dopamine metabolite levels
(Fredriksson et al. 1993); this contrasts with
the increase in activity and dopaminergic sys-
tems associated with PD-like mechanisms.
Other groups have reported that paraquat
administered by intraperitoneal injection can
cross an intact BBB (Corasaniti et al. 1998;
Shimizu et al. 2001). Further experiments sug-
gested the involvement of the neutral amino
acid transporter in the carriage of paraquat into
the brain, followed by transportation into stri-
atal, possibly neuronal, cells, in a Na+-depen-
dent manner (Shimizu et al. 2003). Inhibition
of paraquat uptake into rat striatal tissues,
including dopaminergic terminals, has also
been shown to operate by a speciﬁc dopamine-
transport inhibitor (Shimizu et al. 2001).
Although not directly relevant to human
exposure pathways, paraquat has been shown
to be neurotoxic after direct injection into areas
of the brain (Bagetta et al. 1992; Calò et al.
1990; Corasaniti et al. 1992, 1998; De Gori
et al. 1988; Iannone et al. 1988, 1991).
Depending on the brain region into which the
paraquat was injected, it produced different
behavioral patterns, increased locomotor activ-
ity, and caused convulsions; these effects were
accompanied by neuronal cell death. In gen-
eral, these studies suggest that paraquat neuro-
toxicity is not specific to the dopaminergic
nigrostriatal system because effects were
observed when paraquat was injected into
regions of the brain where other neurotrans-
mitter systems are located.
Several studies have observed neurotoxicity
after systemic administration of paraquat. An
increase in dopaminergic neuronal death in
the SN pars impacta was observed in treated
rats, with no depletion in striatal dopamine
but enhanced dopamine synthesis indicated by
increased tyrosine hydroxylase activity
(McCormack et al. 2002). The authors sug-
gested that the apparent discrepancy between
neurodegeneration and a lack of dopamine
loss was probably a reﬂection of compensatory
mechanisms by which neurons that survive
damage were capable of restoring neurotrans-
mitter tissue levels.
When rats were treated intravenously with
paraquat, the brains had lower complex I
activity and higher levels of lipid peroxides
(indicating free radical activity) and a lower
level of dopamine in the striatum (Tawara
et al. 1996). Mice treated with paraquat
showed an up-regulation and aggregation of
α-synuclein (Manning-Bog et al. 2002).
However, the studies of Woolley et al. (1989)
in mice and of Naylor et al. (1995) in rats
Brown et al.
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Figure 3. Potential mechanisms involved in the development of PD. Pathways are considered interdependent
and are not necessarily mutually exclusive. Adapted from Betarbet et al. (2002).(detailed above) showed no neurotoxic effects
or changes in brain dopamine levels.
Combination of paraquat and maneb.
Maneb [manganese ethylenebisdithiocarbamate
(manganese-EBDTC)] is a dithiocarbamate
herbicide, and the areas of use of maneb and
paraquat have a marked geographic overlap in
the United States (Thiruchelvam et al. 2000a).
Mice exposed to paraquat or maneb, either
alone or in combination, showed a sustained
decrease in motor activity only in the com-
bined exposure groups, with increased striatal
dopamine and dopamine metabolite levels
immediately postinjection, decreasing after
7 days, and reduced levels of tyrosine
hydroxylase and DAT in the dorsal striatum
(Thiruchelvam et al. 2000a, 2000b).
Combined exposure thus potentiated
effects that appear to target the nigrostriatal
dopaminergic systems. The authors suggested
that mixtures of pesticides could play a role in
the etiology of PD. In a series of studies on
developmental exposure to the combined pesti-
cides, mice had reduced motor activity and
striatal dopamine levels (Thiruchelvam et al.
2002). Although the greatest loss of nigro-
striatal dopaminergic cells was seen after com-
bined treatment, there was signiﬁcant loss with
all treatments after rechallenge when adult,
suggesting that a state of silent toxicity had
been unmasked upon adult rechallenge. There
was also evidence that prenatal exposure to
maneb may lead to alterations of the nigro-
striatal dopaminergic system and enhanced
susceptibility to adult exposure to paraquat
(Sherer et al. 2002).
In a further study on mice of different ages
using higher doses (Thiruchelvam et al. 2003),
reduction in locomotor activity and motor
coordination and reduction in dopamine
metabolites and turnover were greatest in the
oldest mice (18 months of age). The decrease
in the number of nigrostriatal dopaminergic
neurons was progressive, particularly in the
oldest mice given paraquat and maneb in
combination. The result demonstrates an
enhanced sensitivity of the aging dopamine
pathway particularly to paraquat and maneb.
Exposure of transgenic mice to maneb
and paraquat showed a higher level dopamin-
ergic neurotoxicity in mice with doubly
mutated α-synuclein compared with mice
expressing normal wild-type human α-synu-
clein (Thiruchelvam et al. 2004).
Another report from the same group
(Barlow et al. 2003) suggested that a number
of different dithiocarbamates potentiate the
toxicity of both MPTP and paraquat in mouse
models of parkinsonism. This included the
increased accumulation of dopamine in synap-
tosomes due to delayed efﬂux.
Dithiocarbamates. There is some evidence
for the neurotoxicity of dithiocarbamates,
including studies on the manganese-containing
pesticide maneb, alone or in combination with
paraquat. Although manganese has been
shown to cause PD-like effects in workers at
high occupational exposure, it affects the
globus pallidus rather than the SN and is also
resistant to the beneficial effects of L-dopa.
However, neurotoxic effects have been
observed in toxicologic studies with the non-
manganese-containing parent compound,
EBDTC, from which maneb is derived
(McGrew et al. 2000).
Acute exposure of mice to maneb led to
central nervous system depressant effects,
including decreased locomotor activity involv-
ing the dopaminergic systems (Morato et al.
1989; Takahashi et al. 1989). EBDTC
(McGrew et al. 2000) and diethyldithiocarba-
mate (Miller et al. 1991) enhance both neu-
robehavioral effects and striatal dopamine
depletion of MPTP in mice. In vitro studies
on rat mesencephalic–striatal primary cocul-
tures, using both mancozeb (manganese-zinc-
EBDTC) and zineb (zinc-EBDTC), showed
similar inhibitory activity on dopamine and
GABA uptake for both compounds (Soleo
et al. 1996). The authors suggested that
EBDTC rather than manganese might be
responsible for the cytotoxic effects on neu-
ronal systems and that the ﬁndings were rele-
vant to the pathophysiology of parkinsonism.
In a study by Zhang et al. (2003), maneb
administered directly to the lateral ventricles of
rats showed induction of dopaminergic neu-
rodegeneration and extensive striatal dopamine
efflux, comparable with that induced by the
metabolite of MPTP, 1-methyl-4-phenylpyri-
dine (MPP+).
Cyclodienes. Bloomquist and colleagues
have carried out studies examining possible
effects of the organochlorine cyclodiene pesti-
cides, in particular, dieldrin and heptachlor, on
possible biomarkers of PD. Heptachlor
increased the maximal rate of striatal dopamine
uptake, which was attributed to induction of
the DAT and a compensatory response to ele-
vated synaptic levels of dopamine (Bloomquist
et al. 1999; Kirby et al. 2001; Miller et al.
1999). Kirby et al. (2001) suggested that hep-
tachlor and perhaps other organochlorine pes-
ticides exert selective effects on striatal
dopaminergic neurons and may play a role in
the etiology of PD. Heptachlor and dieldrin
administered to pregnant rats, although caus-
ing some maternal toxicity, resulted in
increased activity of striatal DAT in offspring
exposed during gestational, perinatal, and ado-
lescent periods (Purkerson-Parker et al. 2001).
There is some evidence that dieldrin may
interfere with electron transport and increase
the generation of superoxide radicals
(Stedeford et al. 2001). In proliferating PC12
cells exposed to dieldrin, there was evidence for
increased oxidative stress. In mesencephalic cell
cultures (Sanchez-Ramos et al. 1998) and
PC12 cells (Kitazawa et al. 2001), there was a
rapid release of dopamine and its metabolite,
followed by apoptotic cell death.
Although the convulsant and proconvul-
sant actions of endosulfan have been attrib-
uted to an antagonistic action on GABA, a
dopaminergic involvement has been suggested
for its induction of hypermotor activity and
circling movement (Ansari et al. 1987; Paul
and Balasubramaniam 1997). Administration
of endosulfan during gestation and lactation
in rats up to 2–3 weeks of age produced a sig-
niﬁcant decrease in the afﬁnity and maximum
numbers of striatal dopaminergic receptors
without affecting other receptor proﬁles, sug-
gesting that dopaminergic receptors are
unusually sensitive to the action of endosulfan
(Seth et al. 1986).
Pyrethroids. During investigations into the
possible involvement of the pyrethroid perme-
thrin and the organophosphate chlorpyrifos on
the etiology of PD and Gulf War illness, mice
treated with permethrin showed increased
dopamine uptake at low doses (e.g., 134% at
1.5 mg/kg), whereas at higher doses dopamine
uptake was depressed [e.g., 50% at 25 mg/kg
(Karen et al. 2001)]. Reduced mitochondrial
function was observed in in vivo synaptosome
preparations, and although striatal dopamine
levels were not decreased, there was an
increased dopamine turnover and decreased
motor activity. Although frank parkinsonism
was not observed, dopaminergic neurotransmis-
sion was affected by exposure to permethrin.
Mice treated with deltamethrin showed a
70% increase in maximal dopamine uptake in
ex vivo synaptosomes suggestive of an up-regu-
lation in DAT expression (Kirby et al. 1999).
Unlike MPTP, deltamethrin did not decrease
dopamine, although there was some evidence
of increased turnover.
When the pyrethroid insecticide fenvaler-
ate was given orally to rats, there was a pro-
nounced, but not dose-related, inhibition of
dopamine and its metabolites and decreased
dopamine binding in several brain regions,
including the corpus striatum (Husain et al.
1991). In another study, fenvalerate or cyper-
methrin given during gestation and lactation to
pregnant and nursing dams (Malaviya et al.
1993) showed a significant increase in
dopamine and muscarinic receptors of striatal
membranes in the pups. Malaviya et al. (1993)
suggested that the ﬁndings demonstrated dis-
turbance of both the dopaminergic and cholin-
ergic pathways.
Other pesticides. Although there is evi-
dence for neurotoxic effects of some other
pesticides, all the mechanistic systems seen in
PD are not consistently effected. A review of
the potential involvement of these other pesti-
cides is presented in the Supplementary
Material (http://ehp.niehs.nih.gov/docs/
2005/8095/supplemental.pdf).
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The formation of Lewy bodies may be integral
to the cause of the disease rather than being an
accompanying effect. Studies in vitro have sug-
gested that a number of pesticides (alone or in
combination with certain metals) may induce a
conformational change in α-synuclein and
accelerate the formation of α-synuclein ﬁbrils
(Uversky et al. 2001, 2002). Pesticides known
to induce this effect are hydrophobic and
include rotenone, DDT, 2,4-dichlorophenoxy-
acetic acid, dieldrin, diethyldithiocarbamate,
paraquat, maneb, trifluralin, parathion, and
imidazoldinethione; those having no signifi-
cant effect include iprodione, glyphosate,
methomyl, thiuram, mevinphos, carbaryl,
alachlor, thiobencarb, and also MPP+ (Uversky
et al. 2001, 2002).
Overall Conclusions
The epidemiologic studies suggest a relatively
consistent association between exposure to pes-
ticides and an increased risk of developing PD,
despite differences in study design, case ascer-
tainment and deﬁnition, control selection, and
pesticide exposure assessment. Particular classes
of pesticides found to be associated with PD
include herbicides, particularly paraquat, and
insecticides; evidence from case reports and
case–control studies for an association with
exposure to fungicides alone is equivocal.
Duration of exposure has also been found to be
a risk factor, with those exposed to pesticides
for > 10 or 20 years being associated with an
increased risk of developing PD. However, in
addition to pesticides, several other risk factors
are associated with an increased risk of devel-
oping PD, including rural living, well-water
consumption, and farming. We found no
studies that have been able to determine
whether these risk factors are independent risk
factors or correlated with pesticide exposure.
The toxicologic evidence suggests that,
with certain routes of administration,
rotenone and paraquat may have neurotoxic
actions that could potentially play a role in
the development of PD. These include effects
on dopaminergic systems in the SN, and
α-synuclein aggregation. There is also some
evidence that the mechanisms of neurotoxicity
associated with exposure to pyrethroids are
those that would be suggestive of a role in the
development of PD and that dithiocarbamates
may interact with other xenobiotic agents to
increase neurotoxicity. Studies on various other
pesticides suggest that, while they have neuro-
toxic actions, they do not act on systems in the
brain of relevance to PD. However, many of
these studies reviewed were designed to elicit
acute toxicity in order to study the mechanisms
of action. We identiﬁed no study that adminis-
tered pesticides at levels comparable with those
encountered by pesticides users, nor were the
routes of administration those that would be
experienced by pesticide users (i.e., oral, inhala-
tion, or dermal). As a result, it is difficult to
interpret the relevance of such studies to
humans, although the difﬁculty in modeling a
disease such as PD is acknowledged. Of poten-
tial toxicologic importance are the few studies
that reported dopaminergic neurotoxicity after
combined low-level exposure to multiple envi-
ronmental neurotoxicants, including paraquat
and maneb, the combined effects of pesticides
and metals on α-synuclein, and rotenone and
lipopolysaccharide (which may be present due
to inflammation or infection). For example,
although PD is a disease of aging, the studies of
Thiruchelvam et al. (2003) on the develop-
mental exposure to maneb and paraquat indi-
cate that early exposure may lead to PD-like
toxic effects upon adult rechallenge. Such stud-
ies suggest that exposure to multiple low-level
environmental neurotoxicants, perhaps at an
early age, may be an etiologic factor in the
development of PD.
Recent toxicologic studies have suggested
that multiple genetic and environmental fac-
tors could be involved in the etiology of PD.
Studies with transgenic mice suggest that the
genetic background and expression of the
α-synuclein gene may have a role to play in
neurodegeneration of the SN (Thiruchelvam
et al. 2004) and may also lead to increased
vulnerability to the neurotoxic effects of the
pesticides maneb and paraquat. There is evi-
dence that developmental exposure to pesti-
cides may have an increased neurodegenerative
effect as well as making the SN more suscepti-
ble to subsequent adult exposure to pesticides,
and that combined exposure to pesticides such
as maneb and paraquat has a greater neuro-
toxic effect than either pesticide alone (Cory-
Slechta et al. 2005). Other recent studies also
suggest some interaction between the neuro-
degenerative effects of pesticides and inﬂam-
matory proteins produced by microglia in the
SN (Gao et al. 2003, Liu and Hong 2003).
These genetic and environmental factors could
be considered in future epidemiologic studies
of this multifactorial disease.
Most of the epidemiologic studies that we
reviewed used a case–control design with rela-
tively small numbers of cases. Pesticide expo-
sure history was, by necessity, collected
retrospectively, generally using questionnaires.
Information and recall bias are inherent limita-
tions of this type of design. The exposure
assessments were also limited in their collection
of information on the types of pesticides, spe-
ciﬁc chemicals, and levels of exposure experi-
enced. Of all the studies we reviewed, the two
most reliable were large case–control studies
that attempted to investigate exposure to dif-
ferent groups of pesticides (Semchuk et al.
1992; Seidler et al. 1996).
Despite these considerations, it seems
unlikely that the relatively consistent association
between PD and reported exposure to pesti-
cides observed in the epidemiology studies
could be explained wholly by a combination of
chance, bias and confounding, and selective
reporting. The toxicologic literature indicates
several areas that would benefit from further
research, including the effect of exposure at dif-
ferent ages, early exposure and developmental
changes, the role of inﬂammatory disease, and
the potential for gene–environment inter-
actions. Epidemiologic studies of an appropri-
ate design and size, that collect detailed
information on exposure to speciﬁc pesticides
and other chemicals, including early life expo-
sures, would be required to investigate these
issues. Studies to date have not had sufﬁcient
power to disentangle the relative importance of
intercorrelated risk factors and to evaluate each
risk with any conﬁdence. We are aware of sev-
eral ongoing studies that are addressing some of
these areas of concern.
In conclusion, the weight of evidence is
sufficient to conclude that a generic associ-
ation between pesticide exposure and PD
exists, but it is not sufﬁcient to conclude that
this is a causal relationship or that such a
relationship exists for any particular pesticide
compound or combined exposure to pesticides
and other exogenous toxicants. In addition,
the multifactorial etiology of PD hampers
unequivocally establishing the role of any indi-
vidual contributory causal factor.
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